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Day (n= 120) Night (n= 198) P
Age (years) 59* 13 60& 14 NS
Males 79% 79’% NS
AnteriorMI 49’% 51% NS
Diabetes mellitus 11% 12”A NS
Multiveaseldisease 39% 420/4 NS
Tma to admission(rein) 173 *63 185 &88 NS
PTCA Succeaa* 93% 94% NS
Time to raperfualon(mIn) 220 * S5 241 +92 NS
Emergerrcy CABG (%) o 0.6% NS
Ventriculartachyaqthmia 8.0% 5.1% NS
Leftventrkwlar EF (%) 53* 12 51 + 13 NS
TIMI 3 at dleehame Ss% 98% NS
In-hospitaldeath” 5.3% 6.9”/. NS
*TIMI 3 flowand .=50% reaidualstenasia
Conclusion:In thrombolysis-eligib16Pte,baseline characteristics and out-
come of primary PTCA appear aimilar at night and during the day. There is
no reason to treat Fts differently during the “off” hours.
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D92625 EarlyRavaacularizstionof AaymptomaticPatiantsWitha TotallyOccludadinfarct-RalatadAttary
ImprovasLaftVentricularRamodaling
G.Dangas, M.E. Goldman, A. Cohen, V. Kakarala, S.K. Sharma,
S. Duwuri, T.P.Cocka, J.D. Marmur, J.A. Ambrose. TheCardiovascular
hrstrtute,MountSinaiMedicalCentecNewYorfc,NY USA
While symptomatic pefiants post Q-wave Ml benefit from earfyeleefive revas-
eularizetion, it is unknown whether esymptomatic patients improve, including
those with a totally cceluded infarct-related artery. We prospectively studied
20 coneeoutiva esymptomatic patients (age 55 + 2 years, 18 males) fol-
lowing a Q-wave Ml (CK 3235 + 450, 18 anterior) with 270% stenosie of
the infarct-related artery who underwent elective ravaacularizetion (day 3-7
post-Ml). Baseline rest echo waa perfommd s 24 hre before revasculariza-
tion, and repeat eeho at 8-week follow-up. All studies wereanalyzed blindly
by two-reader mneenaus, and Ieftventricular volumes and ejection freetiona
(EF) were measured by Simpacm’srule (from apieel 4-chamber view).
f?esuk Compared to patients with patent infarct-related arteries, those
with totally occluded arteries had greater end-systolic volume (117 + 47 ml
vs. 68 & 8 ml) and lower EF (39 + 6% vs. 44 + 2%) at baseline (p = ns).
Patients with total oeelusiona (TIMI flow O or 1) had significant changes in
end-systolic volume and EF (mean + SE) after revaacularization compared
to patients with patent artarfee (TIMI flow 2 or 3):
APOSt – PM TIMI O-1 (n= 5) TIMI 2-3 (n = 15) P
ASyatOliCvoluma –22.2 & 17,1ml 5.1 + 3.4mi 0.02
AEF 13.6+ 7,1% 0.7 * 2.2’% 0.03
Conclusion:Global left ventricular remodeling, as aesessed eehocerdio-
graphieelly, is deereased after elective revascularization early post Q-wave
Ml in esymptomatic patients with totally oeeluded infarct-related arteries.





H.-S. Kim, W. Kim, J.-S. Shen, D.J. Kim, J.-H. Shin, S.-J. Tahk, B.W. Choi.
AjouUniversitySchoolof Medicine,Suwon,Korea
The previoue reports hsve demonstrated that preserved coronary flow re-
serve (CFR) in the infarct region ia aaaociatad with the improvement of wall
motion abnormality after reperfusion in acute myoeerdial infarction. To in-
veatigste the relationship betwwn residual CFR in the infarct related artery
and subsequent left ventricular (LV) remodeling and function, we studied
36 patients (pfs, mean age: 55 + 11 year8, 29 males, 7 females) with the
fimt anterior myoeerdial infarction. Twenly pts reeeived thrombolytic therapy.
Coronary angioplasty was performed in 25 pts 7–10 days after infarction
and mean reaidual stenoaia was 37 + 259’.. CFR was measured dietel to
the infarct lesion by intremronary Doppler wire (0.014-inch) and injection of
adenoaine after angioplasty. Pts were divided into two groups with CFR <
1.3 (n= 13) or ?1.3 (n = 23). End diastolic (EDV) and end syatolic (ESV) LV
volumes and ejection fraction (EF) were measured byfwo dimensional echo-
cardicgraphy and radionuclide angiography 7-10 days (after angioplaety)
and 3 months post infarction.
At3 monthfollow-up CFR <1.3 (n = 13) CFR ? 1.3 (n= 23)
“AAEDV 24.8& 7.8 0.1 +4.2”
% AESV 14.1 + 6.S -11,1 + 12.5$
AEF –2.3 %4.7 6.4*6.3
(*p < 0.05)
Thus, patienta with poor CFR (<1.3) as directly measured in the infarct
relatedartery have more LVdilation than thoeewith relatively presewad CFR.
Therefore, CFR may bea reflection of coronay microvascular integrity which





1.Kugler, P.Gaudron, K. Hu, W. Bauer, C. Eillesl, G. Ertl. Departmentof
MedicineII Mannheim,Universityof Heidelberg,GenrtanH1Regensburg,
Germany
Leffventricular (LV)dilation affermyocardialinfarction (Ml) iaan independent
predictor of adverse eventa and mortality. Asymptomatic patients with small
Ml are eonaidered to be at low risk for LV dilation and late dysfunction.
We prospectively followed 104 asymptomatic normotensive patients after
first Ml without ischemia or reinfarcfion for 7 years. At beeeline, Ml aize
(cineangiography) was 7 + 1% (mean & sem) and 30 + 2% and redi~
nuclide ejection fraction (EF) 53 & 2% and 30 + 2Y0 in small (n = 76) and
large (n= 27) Ml, reapecfively. From 4 days (D), 4 weeke (W), 0.5 years (Y),
1.5 Y, 3 Y until 7 Y after Ml, LV end diaatoiic volume index (EDVI), by gatsd
SPECT increased. This slow LV dilation (figure) in small Ml was followed by
late deterioration of EF (4 D: 53 + 2; 4 W: 54 +2; 1.5Y: 53 + 2; 3Y: 49 +2; 7
Y: 34 + 3t; t ANOVAP <0.05 vs. 4 D). Repeat angiography 72 months after
Ml (n= 9) revealed an increaae in end-diastolic circumference (4 W: 27.6 +
0.6; 72 M: 31.0 + 0.7 cm; p = 0.0119) due to increased Ml eegment length
(4 W: 1.3 + 0.4; 72 M 7,3 + 1.1 cm; p = 0.0005) at unchanged noninfarcted
segment length (4 W: 26.1 + 0.6; 72 M: 24.7 + 1.Scm; p = 0.4608).
EDVI(mt/m2)
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Thus, even after emall Ml, the LV may undergo slow but long-term remod-




M. Alam, L. Graham, G. Divine, S. Borzak, S. Smith, N. Wulbreeht,
H.N. Sabbah, S. Goldetein, F. Khaja. HenryFordHear?and Vascular
hrstitute,Detroit,Ml, USA
In this prospective study, we examinad the extent of LV chamber dilation,
a measure of LV remodeling, following firet Q-wave and non Q-wave (NQ)
acute myoeerdial infarction. A group of 165 petienta with infarction, 120
with Q and 45 with NQ based on pm-hospital discharge ECG were stud-
Baseline 3M 6M
Q-EDVI(mUmz) 56% 16 64& 16* 66k 16t
NO-EOVI (mlh#) 55* 15 63+ 16* 61 + 15f4
Q-ESVI (ml/mz) 27& 10 32+ 12” 33* llt
NO-ESV~(m!4mb) 25+ 10 26 k 8* 28& 10~
*t$p <0,001, * Saaaline vs. 3 M; keallne vs. 6 M; *Q VS.NQ]
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ied. Two-dimensionalachocardiogramswere obtainedwithin48 hoursof




infarctionpatients.EDVIandESViincreasedafter3 Mand6 Mof foiiow-up
in both(2and NQpatients.At 6 M, bothEDVIand ESVIweresignificantly
greaterinQcomparedto NQpatients.Cone/usions:ProgressiveLVchambar
enlargementoccursfollowingboth Q and NQacutemyocardialinfarction.
Theextentof I..Venlargement,however,IsgreaterInQthanin NQinfarction

















and Iaterai,134(34%).For the whoiegroup,the meanLVEFwas49.6 +
14%.The mrrelation barwaanimpaired(EF < 50%)or presarvsd(EF ?
50%)LVfun~ionreveal~ a significantmrrelationbetweenS.t’ItWiOr(X2= 6,
p =0.01) andseptal(X2= 5.6,p = 0.02)involvementbutnotforotherareas.
Theevaluationof regionaiwaiimotionabnormalities(WMA)alsoshoweda
atrongmrralationbetweenanteriorhypoperfuaionandprasanceof anterior
WMA(X2= 15,p = 0.000)andseptalhypoparfusionandsaptalWMA(X2=
8, p < 0.005)butnosignificantrelationshipwasfoundforotherareas.
Cono/usion:Thesefindingsindicatethat,despitelackof Q waves,ante-
riorandaepfalparfuaionabnormalitiesin patientawithnon-Q.waveMl are
oorraiatadwith impairedLVfunction,aa indicatedby lowerLVEFand the
associatedregionalwallmotionabnormalities.
D92630 C-ReectlveProteinee e Predictorof InfarctExnansionandCardiacRuntureAftera FiretQ—--r–..–
WaveAcuteMyocardlalInktion
T.Anzai,T.Yoahikawa,H.Shiraki,Y.Asakura,M.Akaiahi,H.Mifamura,
S.Ogawa.Cardiopulmonary Division, Dapartnrent of Medicine, Keio









withauccassfulrevascularization,and with age <70 yaara.Peaklevelsof
bothCRPandcreaffneIdnaae(CK)werehigherinpatientswithpumpfailure
thaninthoaawithoutpumpfailure.Inpatientawithoardiacrupture,psiakCRP
Iavelawerehigherthanin thosewithoutrupture(23.7& 3.9vs 12.2& 10.6
m~dl, p = 0.001);peakCKIeveiswerenotpradiotive.PeakCRPIeveiscor-
relatedpositivelywith ieft vantricuiar(LV)end-diastolicvolume(p = 0.002)
and inverselywith ejectionfraction(p = 0.0001).HigherCRPieveiawere
foundin patientswithLVaneutysm(p= 0.001vsthosewithout),aggravated
heartfaiiureduringthe firstone yearafterAMI (p= 0.03vs thosewithout)
andone-yearoardiacdeath(p <0.0001 vaaurvivora).Multivariateanaiyaia
confirmedthat an aievationof the peakCRPievelabove20 m@diwasan
independentpradiotorof oardiacrupture(reiativerisk,rr = 4.72,p = 0.004),
Ieffventricuiaraneuryamformation(rr=2.11,P=O.03),andona-yearcardiac
death(rr = 3.45,p = 0.0001).Conclusions: Cardiacrupture,ieft ventricular
aneurysmformationand one-yearcardiacdeathwereassociatedwhhan
elevationof aerumCRPearlyafterAMI,suggestingthat elevationof CRP
iavelaafterAMimaypredictinfarctexpanaion.
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El9271 Usaof Cllostszol,a NovelAntiplateletAgent,asaPost-Palmatz-SchatzStentingRegimen
M.Ochiai,T.Isshiki,S.Takeahita,K.Eto,H.Toyoizumi,T.Sate,
H.Miysshifa.Department of Medicine, Telkyo University Hospital, Tokyo,
Japan
Seckgruund: Tlclopidineachievedwidespreaduseas an antiplateletagent
foliowingPalmatz-Schatzstent (PSS)implantation.However,this drug is
sometimesassociatedwith aarlou$side effects(InciudlngIeukocytopenia
and liverdysfunction).Cliostazol,a potentinhibitorof phosphodiesterase,
is a noveiantiplateletagentwhichis currentlyavaiiablein Japanand be-








23 RCA,and 1 SVG)weretreatedwithPSS.Ail iesionswereexpendadby
usinghigh-pressurebalioonswitha finalbaiioonpressureof 18.6+ 1.6atm
underthe guidanceof quantitativecoronaryangiography.FollowingPSS,









be potentiallyuaefulas a newantiplateletagentfollowingPSSimplantation





Y.Lienhart,C.Grenot,T.Baardman.ICVParia Sud, AntonH France
The MUSTtrial was designadto validatethe conceptdevelopedby the
FrenchRagisttyof coronarystentingwiththeassociationof Ticlopidinaand
Aspirinassolapoststentingtreatment.
Population: from Januaryto August1995,260 pfs were includedin an
open,proapactive,multicanter,observationalstudy.Patientsselaotadhad
stableorunstableangina,a singielesionina nativearterytreatadbyelective
stentingwith a single 15 mm PalmazSchatzstent. Medicaltherapy:the
patientsraoaived100mgAspinnand250to 500 mgof Ticiopidindailyfor
onemonthaftertheprocedure.
Prooadure: 3 (1.15%) stentingproceduresfaiiad(2crossoverto awiktor
stent),3(1.15YO)stentswerelost.
/n-frospita/avenfs:nopetientdied,1(0.4%)underwentemergencyaurgery,









6 montheventrateseemscomparablewiththoseof the atentadarmof the
Benestentstudies.
